Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Healios KK Ord Shs HLOSF

Healthcare Biotechnology
Healios KK is a Japan-based company mainly engaged in business in the somatic stem cell regenerative medicine field and in the iPSC regenerative medicine field, which involves research, development and manufacture of regenerative medicine products (iPSC regenerative medicines) utilizing technologies related to induced pluripotent stem cells (iPS cells, iPSCs). The somatic stem cell regenerative medicine field develops and markets cell therapy drugs for acute stroke and acute respiratory distress syndrome using MultiStem, a somatic stem cell product for which the Company holds patent and patent licensing rights. The iPSC regenerative medicines include the creation of universal donor cells (UD), next-generation iPSCs that reduce the risk of immune rejection regardless of human leukocyte antigen (HLA) type using gene editing technology.


PINL:HLOSF - Post by User

Healios KK Ord Shs > Listen!!! IT WILL BE OPEN PIT MINE!!!!
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by Prospector43on Nov 15, 2010 7:30pm
157 Views
Post# 17709815

RE: Listen!!! IT WILL BE OPEN PIT MINE!!!!

RE: Listen!!! IT WILL BE OPEN PIT MINE!!!!
I AGREE WITH AMA 100 PERCENT !!!
I HAVE BEEN IN THE MINING BUSINESS FOR OVER 45 YEARS AND I'VE SEEN A LOT AND HEARD A LOT IN ALL THOSE YEARS.
HLO HAS THE MAKINGS OF A VERY PROFITABLE OPEN PIT MINE AND THEY REALLY SHOULD GET THE BALL ROLL'N. METAL PRICES ARE HIGH AND EVERY COUNTRY IS SCRAMBLING TO GET THEIR HANDS ON PROPERTIES LIKE HALOS !!!


Who cares!!! 75% are open pitable !! Ask Lynda Bloom for your Education 101, dont waste your time here!!

Who cares which way you cut off

" Open Pit tonnage in the indicated and inferred category is as follows:

262 million lbs of Copper
352 million lbs of Zinc
160,000 oz of gold
3.3 million oz of silver.

Very Impressive tonnage. Mining infrastructure to be built !  HLO is very undervalued in my opinion. $1-$2 stock price would be fair with only 18 million shares out. "
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities